Stock-Based Compensation - Schedule of Stock Option Activity (Details) - $ / shares |
3 Months Ended | 11 Months Ended | |
|---|---|---|---|
Dec. 31, 2024 |
Mar. 31, 2025 |
Dec. 31, 2024 |
|
| Schedule of Stock Option Activity [Line Items] | |||
| Outstanding Shares, Balance | 3,247 | 23,560 | 3,247 |
| Weighted Average Exercise Price Per Share, Balance | $ 200 | $ 52.2 | $ 200 |
| Weighted Average Remaining Contractual Life (in years), Balance | 9 years 7 months 20 days | 9 years 10 months 9 days | |
| Outstanding Shares, Options exercisable as of ending | 2,474 | 3,550 | 2,474 |
| Weighted Average Exercise Price Per Share, Options exercisable as of ending | $ 200 | $ 151.2 | $ 200 |
| Weighted Average Remaining Contractual Life (in years), Options exercisable as of ending | 9 years 6 months 25 days | 9 years 8 months 4 days | |
| Outstanding Shares, Options granted | 20,313 | ||
| Weighted Average Exercise Price Per Share, Options granted | $ 28.6 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|